XML 126 R39.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock Plans (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Weighted-Average Black-Scholes Fair Value Assumptions
Our weighted-average Black-Scholes and Lattice Model fair value assumptions were:
 
Risk-Free
Interest Rate
 
Expected Life
 
Expected
Volatility
 
Expected
Dividend Yield
 
Fair Value
at Grant Date
2019
2.46
%
 
5 years
 
19.96
%
 
2.37
%
 
$
7.83

2018
2.68
%
 
5 years
 
20.96
%
 
2.02
%
 
$
8.30

2017
2.04
%
 
6 years
 
22.75
%
 
1.74
%
 
$
8.57


Schedule of Stock Options Activity
Stock option activity is reflected below:
 
Shares Subject
to Option
 
Weighted-
Average
Exercise or
Grant Price
Per Share
 
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
Balance at January 1, 2017
53,601,612

 
$
28.02

 
 
 
$
874
 million
Annual grant to eligible employees
6,012,140

 
43.20

 
 
 
 
Additional options issued
162,880

 
42.54

 
 
 
 
Total options granted
6,175,020

 
43.18

 
 
 
 
Options exercised (1)
(9,431,009
)
 
26.17

 
 
 
$
170
 million
Options cancelled
(1,910,968
)
 
38.10

 
 
 
 
Balance at December 31, 2017
48,434,655

 
29.92

 
 
 
$
626
 million
Annual grant to eligible employees
5,666,530

 
43.51

 
 
 
 
Additional options issued
168,306

 
31.40

 
 
 
 
Total options granted
5,834,836

 
43.16

 
 
 
 
Options exercised (1)
(9,333,271
)
 
25.16

 
 
 
$
170
 million
Options cancelled
(1,117,390
)
 
42.93

 
 
 
 
Balance at December 31, 2018
43,818,830

 
32.36

 
 
 
$
371
 million
Annual grant to eligible employees
4,793,570

 
47.72

 
 
 
 
Additional options issued
68,420

 
50.82

 
 
 
 
Total options granted
4,861,990

 
47.76

 
 
 
 
Options exercised (1)
(13,668,354
)
 
27.53

 
 
 
$
306
 million
Options cancelled
(1,156,518
)
 
42.22

 
 
 
 
Balance at December 31, 2019
33,855,948

 
36.19

 
5 years
 
$
640
 million
Exercisable at December 31, 2019
25,121,711

 
32.89

 
4 years
 
$
557
 million
 
(1)
Cash received from options exercised was $369 million in 2019, $231 million in 2018 and $257 million in 2017. The actual tax benefit realized and recorded in the provision for income taxes for the tax deductions from the option exercises totaled $40 million in 2019, $21 million in 2018 and $31 million in 2017.
Deferred Stock Units, Performance Units and Restricted Stock  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Schedule of Deferred Stock Units, Performance Share Units and Restricted Stock Activity
Our performance share unit, deferred stock unit and restricted stock activity is reflected below:
 
Number
of Shares
 
Grant Date
 
Weighted-Average
Fair Value
Per Share (4)
 
Weighted-Average
Aggregate
Fair Value (3)
Balance at January 1, 2017
7,593,627

 
 
 
$
36.90

 
 
Annual grant to eligible employees:
 
 
Feb. 16, 2017
 
 
 
 
Performance share units
1,087,010

 
 
 
43.14

 
 
Deferred stock units
845,550

 
 
 
43.20

 
 
Additional shares granted (1)
1,537,763

 
Various
 
42.22

 
 
Total shares granted
3,470,323

 
 
 
42.75

 
$
148
 million
Vested (2) (3)
(2,622,807
)
 
 
 
35.78

 
$
94
 million
Forfeited (2)
(771,438
)
 
 
 
38.69

 
 
Balance at December 31, 2017
7,669,705

 
 
 
39.74

 
 
Annual grant to eligible employees:
 
 
Feb. 22, 2018
 
 
 
 
Performance share units
1,048,770

 
 
 
51.23

 
 
Deferred stock units
788,310

 
 
 
43.51

 
 
Additional shares granted (1)
446,752

 
Various
 
41.78

 
 
Total shares granted
2,283,832

 
 
 
46.72

 
$
107
 million
Vested (2) (3)
(2,511,992
)
 
 
 
38.91

 
$
98
 million
Forfeited (2)
(882,535
)
 
 
 
42.00

 
 
Balance at December 31, 2018
6,559,010

 
 
 
42.19

 
 
Annual grant to eligible employees:
 
 
Feb. 22, 2019
 
 
 
 
Performance share units
891,210

 
 
 
57.91

 
 
Deferred stock units
666,880

 
 
 
47.72

 
 
Additional shares granted (1)
205,073

 
Various
 
54.81

 
 
Total shares granted
1,763,163

 
 
 
53.69

 
$
95
 million
Vested (3)
(2,007,848
)
 
 
 
37.81

 
$
76
 million
Forfeited
(652,380
)
 
 
 
45.88

 
 
Balance at December 31, 2019
5,661,945

 
 
 
46.90

 
 


(1)
Includes performance share units and deferred stock units.
(2)
Includes performance share units, deferred stock units and historically granted restricted stock.
(3)
The actual tax benefit/(expense) realized and recorded in the provision for income taxes for the tax deductions from the shares vested totaled $2 million in 2019, $3 million in 2018 and $7 million in 2017.
(4)
The grant date fair value of performance share units is determined based on the Monte Carlo simulation model for the market-based total shareholder return component and the closing market price of the Company’s stock on the grant date for performance-based components. The Monte Carlo simulation model incorporates the probability of achieving the total shareholder return market condition. Compensation expense is recognized using the grant date fair values regardless of whether the market condition is achieved, so long as the requisite service has been provided.